Transforming the treatment landscape for unresectable hepatocellular carcinoma: A perspective on transarterial chemoembolization-anchored triple-combination therapy.
- DOI
- 10.1016/j.hbpd.2026.07.011
- Published
- 2026 Jul 29
- Container
- Hepatobiliary & pancreatic diseases international : HBPD INT
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.hbpd.2026.07.011,
title = {Transforming the treatment landscape for unresectable hepatocellular carcinoma: A perspective on transarterial chemoembolization-anchored triple-combination therapy.},
author = {Jiang WY and Feng JK and Zhang Y and Zhang JD and Hu XQ and Cheng SQ and Zhang TS},
year = {2026},
journal = {Hepatobiliary \& pancreatic diseases international : HBPD INT},
doi = {10.1016/j.hbpd.2026.07.011},
url = {https://doi.org/10.1016/j.hbpd.2026.07.011}
}RIS
TY - JOUR TI - Transforming the treatment landscape for unresectable hepatocellular carcinoma: A perspective on transarterial chemoembolization-anchored triple-combination therapy. AU - Jiang WY AU - Feng JK AU - Zhang Y AU - Zhang JD AU - Hu XQ AU - Cheng SQ AU - Zhang TS PY - 2026 JO - Hepatobiliary & pancreatic diseases international : HBPD INT DO - 10.1016/j.hbpd.2026.07.011 UR - https://doi.org/10.1016/j.hbpd.2026.07.011 ER -
APA
WY, J., JK, F., Y, Z., JD, Z., XQ, H., SQ, C., & TS, Z. (2026). Transforming the treatment landscape for unresectable hepatocellular carcinoma: A perspective on transarterial chemoembolization-anchored triple-combination therapy.. Hepatobiliary & pancreatic diseases international : HBPD INT. https://doi.org/10.1016/j.hbpd.2026.07.011
Source records
- pubmed · retrieved 2026-09-26T05:20:16.518Z